Search the Newsreel

Atlanticus Holdings Corp (ATLC) Shares Surge 5.7% -- What GF Sco

Atlanticus Holdings Corp (ATLC) shares rose 5.7% to $102.53, with GuruFocus identifying the stock as 40.5% undervalued compared to its GF Value™ of $172.26. Despite a strong GF Score™ of 66/100 and high momentum, the company faces concerns regarding its low financial strength (2/10) …

Insider Selling: Cue Biopharma (NASDAQ:CUE) CEO Sells 18,258 Shares

Cue Biopharma CEO Shao-Lee Lin sold 18,258 shares of the company's stock for over $522,000 to cover tax withholding obligations from vested equity awards. This sale reduced her ownership by 2.52%, following a previous sale of 40,000 shares for $1.08 million. The company recently …

Cue Biopharma CEO Lin sells shares worth $1.6 million

Cue Biopharma CEO Lin Shao-Lee sold shares worth $1.6 million, primarily to cover tax obligations from vested restricted stock units, not as discretionary sales. Concurrently, Mr. Lin acquired 109,179 shares from vested performance stock units. The company has also appointed a new Chief Medical …

Insider plans 58,258-share stock sale (NASDAQ: CUE) under Rule 144

An insider of Cue Biopharma (NASDAQ: CUE) has filed a Rule 144 notice to sell up to 58,258 shares of common stock. These shares originated from restricted stock units that vested on August 1, 2026. The sale is planned to occur in two tranches …

Kratos Defense CEO Eric DeMarco sells $19.3 million in stock

Kratos Defense & Security Solutions CEO Eric M. DeMarco sold 300,000 shares of company stock worth approximately $19.3 million on August 14, 2026, executed under a 10b5-1 trading plan. This sale occurred despite a 27% decline in Kratos shares over the past six months. …

Moleculin Biotech Releases Q2 2026 Financial Results

Moleculin Biotech (MBRX) reported a net loss of $7.6 million for Q2 2026, with a significant improvement in loss per share, narrowing to $1.40 from $12.25 in Q2 2025. The company, focused on therapeutic candidates for tumors and viruses, generated no revenue but continued …

Cue Biopharma (NASDAQ:CUE) Posts Quarterly Earnings Results, Misses Estimates By $22.45 EPS

H.C. Wainwright reiterates Buy on 4D Molecular stock, $36 target By Investing.com

H.C. Wainwright has reiterated a Buy rating on 4D Molecular Therapeutics (NASDAQ:FDMT) with a $36.00 price target, citing positive two-year data from the Phase 2b PRISM trial for its 4D-150 gene therapy. The company has also completed enrollment for its pivotal Phase 3 4FRONT-2 …

Kratos Defense & Security Solutions (NASDAQ:KTOS) Shares Up 2.9% - Time to Buy?

AtriCure (ATRC) Is Up 10.1% After Unveiling 2030 Revenue Goal And Trial-Driven Expansion Plans

AtriCure (ATRC) saw a 10.1% stock increase after announcing a goal of US$1.00 billion in revenue by 2030, driven by its atrial fibrillation, left atrial appendage management, and postsurgical pain-management franchises, alongside new product launches. The company's expansion plans heavily rely on the successful …

BroadBand Security, Inc. FY2026 Full-Year Financial Results Briefing

Curbline Properties (NYSE:CURB) Director Sells 135,612 Shares

Curbline Properties (NYSE:CURB) Director Alexander Otto sold 135,612 shares at an average price of $30.15, totaling approximately $4.09 million. This transaction, along with other recent sales in August, indicates ongoing insider selling activity, reducing his direct ownership by 1.8% to 7.41 million shares. Despite …

Alexander Otto (CURB) reports 7.4M-share stake and recent stock sales

Alexander Otto has reported beneficial ownership of 7,411,219 shares of Curbline Properties Corp. (CURB), which represents 6.4% of the company's outstanding common stock. This is based on 115,038,025 shares outstanding as of July 22, 2026. Otto also disclosed several open market sales of CURB …

Curbline Properties Corp. (CURB) director reports sale of 231,943 shares near $30

Curbline Properties Corp. Director Otto Alexander reported the sale of 231,943 shares of common stock in two open-market transactions on August 12 and 13, 2026. The shares were sold at weighted average prices of $30.06 and $30.15 respectively, totaling approximately $6.98 million. Following these …

Fuller & Thaler boosts disclosure of 5.19% ICU Medical (ICUI) ownership stake

Fuller & Thaler Asset Management, Inc. has filed an amended Schedule 13G, disclosing a 5.19% beneficial ownership stake in ICU Medical (ICUI). The firm holds 1,298,126.96 shares, with sole voting power over 1,276,819.96 shares and sole dispositive power over all 1,298,126.96 shares. The filing, …

Moleculin Biotech (NASDAQ: MBRX) seeks reverse split and plan changes at 2026 meeting

Moleculin Biotech (NASDAQ: MBRX) is holding its 2026 annual shareholder meeting on October 9, 2026, where key proposals include electing directors, ratifying the independent auditor, and approving an amendment to the 2024 Equity Incentive Plan to increase authorized shares. Shareholders will also vote on …

Jabil Inc. stock underperforms Friday when compared to competitors

Shares of Jabil Inc. (JBL) fell 1.94% on Friday, closing at $363.10. This underperformance occurred during a generally poor trading session where the S&P 500 Index and Dow Jones Industrial Average also declined. The stock's drop ended a three-day winning streak for Jabil Inc.

IceCure Medical (ICCM) expands 2024 employee share incentive reserve

IceCure Medical Ltd. has increased the ordinary shares reserved for its 2024 Employee Equity Incentive Plan by 2,500,000, bringing the new total to 2,612,667 ordinary shares. This expansion, approved by the board on August 11, 2026, provides additional capacity for future equity awards to …

Celcuity (NASDAQ:CELC) Releases Quarterly Earnings Results, Misses Estimates By $0.28 EPS

Celcuity (NASDAQ:CELC) recently reported its quarterly earnings, missing analyst estimates with a loss of $1.44 per share against a consensus of $1.16, and revenue of $0.09 million, significantly below the $4.42 million forecast. Despite the financial miss, the company highlighted the FDA approval of …

KRATOS DEFENSE & SECURITY SOLUTIONS, INC. SEC Filing (Aug 14, 2026)

This article details an SEC Form 144 filing by KRATOS DEFENSE & SECURITY SOLUTIONS, INC. (KTOS) on August 14, 2026. The filing indicates a proposed sale of 300,000 shares of common stock, acquired as Restricted Stock Units on January 3, 2014, with an aggregate …

Did Slower Net Interest Income Growth Just Shift Customers Bancorp's (CUBI) Investment Narrative?

Analysts are questioning Customers Bancorp's (CUBI) investment narrative due to slower net interest income growth and a low net interest margin compared to peers. The bank's earnings per share have not kept pace with revenue, raising concerns about its ability to convert growth into …

JBL|Jabil Inc|Price:363.160|Chg%:-7.200

This article provides a detailed overview of Jabil Inc (JBL) stock, including its current price, market performance, key financial figures, and analyst ratings. Jabil Inc's stock score is -0.02, with a target price of $426.544, indicating a "Buy" rating from analysts. The company specializes …

Curis: Q2 Earnings Snapshot

Curis Inc. (CRIS) reported a second-quarter loss of $8.6 million, which translates to a loss of $4.02 per share. This information was generated by Automated Insights using data from Zacks Investment Research.

Pop Culture Group (CPOP): Alyeska discloses 9.99% stake via shares and warrants

Alyeska Investment Group, L.P., along with Alyeska Fund GP, LLC and Anand Parekh, has disclosed a 9.99% beneficial stake in Pop Culture Group Co., Ltd. (CPOP). This stake, reported via a SCHEDULE 13G filing, comprises 1,346,764 Class A Ordinary Shares, including shares held outright …

Agriculture & Natural Solutions (ANSC) to redeem shares and wind down SPAC

CURIS INC 10-Q Summary: Revenue $0 Net income ($8.58M), EPS ($4.02) — 10-Q Summary

CURIS INC (CRIS) reported its Q2 2026 financial results, showing no revenue and a net loss of ($8.58M), an improvement from the prior-year quarter's net loss. The company's clinical focus has shifted to emavusertib combination trials, and regulatory engagement for accelerated approvals is ongoing. …

Cycurion, Inc. 2026: Revenue $3.76M, EPS ($0.41) — 10-Q Summary

Cycurion, Inc. (CYCU) reported its 2026 quarterly results, showing revenue of $3.76 million and a diluted loss per share of ($0.41). The company achieved a narrower net loss compared to the prior year, attributed to an acquisition and improved margins. Business highlights include integrating …

Security National Financial (SNFCA) Q2 2026 Earnings Call: Profit Rises as Revenue Falls

Four Oculis directors' restricted stock units vest in Aug. 13 notifications

Oculis (NASDAQ: OCS) announced that restricted stock units (RSUs) granted to directors Anthony Rosenberg, Christina Ackermann, Arshad Khanani, and Robert Warner vested on August 13, 2026. The company published notifications regarding these vesting and settlement transactions. While the announcement confirms the RSU vests for …

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

Oculis Holding AG has published notifications regarding transactions by persons discharging managerial responsibilities. These notifications relate to the vesting and settlement of Restricted Stock Units (RSUs) previously granted to company directors. The listed individuals include Anthony Rosenberg, Christina Ackermann, Arshad Khanani, and Robert Warner, …

Cullinan Therapeutics, Inc. - Common Stock (CGEM) Stock Price, News, Quote & History

This article provides comprehensive information on Cullinan Therapeutics, Inc. (CGEM), including its current stock price, financial metrics, and a history of recent news and press releases. The company, a biopharmaceutical firm, focuses on developing cancer therapies and has announced several key clinical milestones and …

EXICURE, INC. Q2 2026: Revenue $0 Net income $(1.12M) — 10-Q Summary

EXICURE, INC. reported Q2 2026 results with no revenue and a net loss of $(1.12M), an improvement year-over-year. The company has shifted its strategic focus to supporting clinical programs for GPCR USA post-acquisition, implementing operational cutbacks, and addressing Nasdaq compliance issues. Financial highlights include …

AllianceBernstein reports 6.7% Strattec Security Corp (STRT) ownership stake

AllianceBernstein L.P. has filed an amended Schedule 13G, disclosing a beneficial ownership stake of 6.7% in Strattec Security Corp (STRT), totaling 278,144 common shares. This ownership is held solely for investment purposes on behalf of client discretionary investment advisory accounts. AllianceBernstein maintains sole voting …

Avoiding Lag: Real-Time Signals in (SRL) Movement

Scully Royalty Ltd. (NYSE: SRL) is showing strong near and mid-term sentiment, with a potential for long-term extension. AI models have generated three trading strategies (position, momentum breakout, risk hedging) with an exceptional 73.5:1 risk-reward setup targeting a 27.9% gain versus 0.4% risk. The …

Sprott Focus Trust (FUND) schedules 2026 meeting to re-elect Class II director

American Century entities (NYSE: MCS) disclose 5.0% beneficial stake in The Marcus Corporation

American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research have collectively disclosed a 5.0% beneficial ownership stake in The Marcus Corporation (NYSE: MCS), totaling 1,197,597 shares as of June 30, 2026. The entities report sole voting and …